Press Releases Dermapharm Holding SE

Equities

DMP

DE000A2GS5D8

Market Closed - Xetra Other stock markets 11:35:18 2024-05-27 am EDT			5-day change	1st Jan Change
37 ^EUR	+0.41%		-1.07%	-12.61%

May. 15	Drug manufacturer Dermapharm starts the new year with declines	DP
May. 15	WDH/Pharmaceuticals manufacturer Dermapharm starts the new year with declines	DP

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dermapharm : INFORMATION PURSUANT TO TABLE 3 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212 (GERMAN)	May. 27	PU
Dermapharm : COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT	May. 27	PU
DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy	May. 22	EQ
Dermapharm : WEBCAST Q1 2024 Transcript	May. 16	PU
Dermapharm : WEBCAST Q1 2024 Transkript	May. 16	PU
Dermapharm : Corporate News Q1/2024 (english)	May. 15	PU
Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy	May. 15	EQ
Dermapharm : Webcast Q1/2024	May. 14	PU
AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	May. 08	EQ
DD: Dermapharm Holding SE: Wilhelm Beier, buy	Apr. 10	EQ
DD: Dermapharm Holding SE: Anja Schorn, buy	Mar. 28	EQ
Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges	Mar. 28	EQ
Dermapharm : CORPORATE NEWS 240328 EN	Mar. 26	PU
AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Mar. 21	EQ
Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business	Mar. 14	EQ
Dermapharm : 20240314 EBITDA 2023	Mar. 12	PU
DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy	Nov. 23	EQ
Dermapharm Holding SE builds on success in Q3 2023	Nov. 15	EQ
AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	Nov. 07	EQ
Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall	23-08-29	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Dermapharm Holding SE

Equities

DMP

DE000A2GS5D8

Press Releases

Filters